Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/curis-enters-into-agreement-for-emavusertib--pembrolizumab-combination-study-in-melanoma-302005577.html

PR NEWSWIRE
05 Dec 2023

https://endpts.com/fda-lifts-partial-hold-on-curis-phi-ii-leukemia-study-as-biotech-raises-15m/

Paul Schloesser ENDPTS
07 Jul 2023

https://www.onclive.com/view/fda-lifts-partial-clinical-hold-on-takeaim-leukemia-trial-of-emavusertib-in-aml-mds

ONCLIVE
07 Jul 2023
FDA puts Curis' leukemia trial on partial hold after patient death
FDA puts Curis' leukemia trial on partial hold after patient death

04 Apr 2023

// Nick Paul Taylor FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/fda-puts-curis-leukemia-trial-partial-hold-after-patient-death-spurs-review-muscle

Nick Paul Taylor FIERCE BIOTECH
04 Apr 2023

https://www.fiercebiotech.com/biotech/fda-sparks-hope-curis-lets-biotech-resume-enrollment-part-phase-12-leukemia-study

Gabrielle Masson FIERCEBIOTECH
31 Aug 2022

https://www.labiotech.eu/trends-news/chris-lymphoma-study/

Jim Cornall LABIOTECH
19 Aug 2022